Connor, Clark & Lunn Investment Management (CC&L)’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-28,465
| Closed | -$882K | – | 1229 |
|
|
2022
Q4 | $882K | Sell |
28,465
-37,369
| -57% | -$1.16M | 0.01% | 737 |
|
|
2022
Q3 | $1.68M | Sell |
65,834
-7,444
| -10% | -$190K | 0.01% | 530 |
|
|
2022
Q2 | $1.49M | Sell |
73,278
-5,149
| -7% | -$105K | 0.01% | 531 |
|
|
2022
Q1 | $1.94M | Sell |
78,427
-9,642
| -11% | -$239K | 0.01% | 506 |
|
|
2021
Q4 | $3.06M | Buy |
88,069
+187
| +0.2% | +$6.5K | 0.01% | 437 |
|
|
2021
Q3 | $2.38M | Buy |
87,882
+7,733
| +10% | +$210K | 0.01% | 490 |
|
|
2021
Q2 | $2.08M | Buy |
80,149
+1,532
| +2% | +$39.7K | 0.01% | 531 |
|
|
2021
Q1 | $1.69M | Buy |
78,617
+3,000
| +4% | +$64.6K | 0.01% | 598 |
|
|
2020
Q4 | $1.63M | Sell |
75,617
-11,834
| -14% | -$254K | 0.01% | 553 |
|
|
2020
Q3 | $1.29M | Sell |
87,451
-19,340
| -18% | -$285K | 0.01% | 572 |
|
|
2020
Q2 | $2.39M | Sell |
106,791
-2,109
| -2% | -$47.1K | 0.02% | 420 |
|
|
2020
Q1 | $1.54M | Buy |
108,900
+18,600
| +21% | +$263K | 0.01% | 471 |
|
|
2019
Q4 | $1.47M | Buy |
+90,300
| New | +$1.47M | 0.01% | 473 |
|